In one paragraphArticle in Diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Commented on by
- Comment on
5 · Who and what moneyAuthors and funding
3 authors.
Andrew S TerkerDivision of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN andrew.s.terker@vumc.org ray.harris@vanderbilt.edu.ORCID 0000-0003-1498-9043 Ming-Zhi ZhangDivision of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Raymond C HarrisDivision of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN andrew.s.terker@vumc.org ray.harris@vanderbilt.edu.ORCID 0000-0001-8025-0883 Funding
The Role of the EGF Receptor in Acute and Chronic Renal InjuryR01DK051265 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 1997 to 2026
$10.1MThe role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulationR01DK062794 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 2003 to 2026
$9.4MThe Role of renal macrophages in recovery from renal injuryR01DK095785 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 2013 to 2026
$6.7MNovel Integrated Analyses of Human Diabetic NephropathyR24DK103067 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAPRIOLI, RICHARD M, DENNY, JOSHUA C. · 2014 to 2018
$6.5MVanderbilt O'Brien Kidney Center - Core D - Clinical and Translational CoreP30DK114809 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, RAYMOND C. · 2017 to 2021
$5.9MVANDERBILT NEPHROLOGY TRAINING PROGRAMT32DK007569 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, RAYMOND C., IKIZLER, TALAT ALP · 1988 to 2024
$5.8MThe Role of Cyclooxygenase-2 in Podocyte Injury in Diabetic NephropathyI01BX000320 · VA · VETERANS HEALTH ADMINISTRATION · PI RAYMOND C. HARRIS · 2009 to 2026
–BLRD VA I01 BX000320NIDDK NIH HHS P30 DK114809NIDDK NIH HHS R01 DK051265NIDDK NIH HHS R01 DK062794NIDDK NIH HHS R01 DK095785NIDDK NIH HHS R24 DK103067NIDDK NIH HHS T32 DK007569
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes MellitusDiabetic NephropathiesPharmaceutical PreparationsHumansPteridinesTranscriptomeBI 2536Pharmaceutical PreparationsPteridines
Identifiers
PMID33472948
PMCPMC7881867
What OpenQuestion holds
Textmetadata
Read underepoch 390